bit.bio’s Founder and former CEO Dr Mark Kotter on creating every cell type and kickstarting a cell therapy revolution.
01.09.2022
Charles River Vital Science podcast talks to CEO Mark Kotter
Mark Kotter talks about the benefits of human cells for researchers, and how they can shape the future of drug development.
bit.bio CEO featured on the Built with Biology podcast
bit.bio CEO Dr Mark Kotter interviewed by Fiona Mischel on the Built with Biology Podcast.
bit.bio CEO featured on the Hightech Ventures podcast
They ask about reprogramming cells and how the company is aiming to develop cell therapies.
bit.bio on the Naked Scientist
Founder and CEO Mark Kotter talks to Eva (The Naked Scientist podcast) about all things cell reprogramming.
Dr Ramy Ibrahim discusses cell therapy
Episode 3 of our special three part mini-series.
Founder and former CEO Dr Mark Kotter talks reprogrammed human cells for research and drug development
The conversation covers our opti-ox technology and its potential for cell therapies.
The story of bit.bio on the Healthtech Podcast
The conversation covers the promise of reprogrammed human cells for therapies and drug discovery.
Dr Paul Morrill discusses bit.bio’s central core – episode 2 of a Pint of Science mini-series
Episode 2 of our special three part mini-series.